ICAAC 52nd (2012)

Drupal spam blocked by CleanTalk.
Title Content type
In vitro activity of Isavuconazole against a worldwide collection of 237 Aspergillus terreus isolates and compared with 7 other Aspergillus active antifungal drugs tested with EUCAST and CLSI methodology (click for details)
In Vitro Activity of Isavuconazole Against Cryptococcus Isolates – A Pooled Analysis of 3 Studies (click for details)
Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of CYP3A4 Substrate Midazolam in Healthy Volunteers (click for details)
Isavuconazole (ISA) Pharmacodynamic (PD) Target Determination for C. albicans (CA) in an in vivo Neutropenic Murine Model of Invasive Candidiasis (IC) (click for details)
In Vitro Immunopharmacodynamics of Cell Wall Active Antifungals Against Candida albicans and Aspergillus fumigatus (click for details)
An in Vitro Pharmacokinetic/Pharmacodynamic Model Predicts in vivo Outcome of Voriconazole Treatment against Aspergillus fumigatus Isolates with Reduced Azole Susceptibility (click for details)
Influence of CYP2C19 and ABCB1 Genetic Polymorphisms on Voriconazole Levels in Haematological Patients (click for details)
Airway Invasive Pulmonary Aspergillosis (IPA) vs Angio-IPA Have Distinct Risk Factors and Outcomes in Lung Transplant Recipients (click for details)
Drug Concentrations in Urine Following Single, Multiple or Intermittent Treatment with Increasing Doses of Liposomal Amphotericin B (LAmB) Versus Amphotericin B (amp) (click for details)
In Vitro Activity of Isavuconazole against a Worldwide Collection of 237 Aspergillus Section Terrei Isolates and Compared with 7 other Aspergillus Active Antifungal Drugs Tested with EUCAST and CLSI Methodology (click for details)


Subscribe to ICAAC 52nd (2012)